# MBX Biosciences, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:a903ee7a-3103-47c0-a978-e15cee24f109 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/mbx-biosciences-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 23 |
| Claims under review | 1 |
| Evidence records | 6 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-08T04:45:48.730395+00:00 |
| Last reviewed | 2026-10-08T04:45:48.730395+00:00 |

## Identity

- Legal name: MBX Biosciences, Inc.
- Display name: MBX Biosciences, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-08T22:32:25.832226+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.825 |
| Directors | 12 |
| Committees | 2 |
| Governance events | 8 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Carl L. Gordon: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-22. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:6
- Edward T. Mathers: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-22. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:7
- James M. Cornelius: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-22. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:8
- Ora Pescovitz: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-22. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:10
- Patrick J. Heron: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-22. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:13
- Steven Ryder: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-22. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:14
- Tiba Aynechi: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-22. Committees: AUDIT COMMITTEE OF THE BOARD OF (member). claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:16
- Laurie Stelzer: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:9
- Ora Pescovitz, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:11
- P. Kent Hawryluk: President, Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Director (member). claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:12
- Steven L. Hoerter: Executive Chair of the Board of Directors. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:5
- Steven Ryder, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:15

## Committees

- AUDIT COMMITTEE OF THE BOARD OF (audit). Chair: NOT_PUBLISHED. Members: Tiba Aynechi (member, current); Tiba Aynechi (member, unknown). committee_id=alpha:committee:mbx-biosciences-inc:audit-committee-of-the-board-of
- Chief Executive Officer and Director (executive). Chair: NOT_PUBLISHED. Members: P. Kent Hawryluk (member, unknown). committee_id=alpha:committee:mbx-biosciences-inc:chief-executive-officer-and-director

## Executive leadership

- Salomon Azoulay: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:20
- John Smither: Interim Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:17
- P. Kent Hawryluk: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:18
- Richard Bartram: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:19
- Salomon Azoulay, M.D.: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:21

## Governance events

- DIRECTOR_APPOINTED: Carl L. Gordon seat on MBX Biosciences, Inc., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-08T04:45:48.730395+00:00. event_id=alpha:event:director_appointed:1sqe5ku
- DIRECTOR_APPOINTED: Edward T. Mathers seat on MBX Biosciences, Inc., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-08T04:45:48.730395+00:00. event_id=alpha:event:director_appointed:12zov81
- DIRECTOR_APPOINTED: James M. Cornelius seat on MBX Biosciences, Inc., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-08T04:45:48.730395+00:00. event_id=alpha:event:director_appointed:1htb8k6
- DIRECTOR_APPOINTED: Ora Pescovitz seat on MBX Biosciences, Inc., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-08T04:45:48.730395+00:00. event_id=alpha:event:director_appointed:7d0ckg
- DIRECTOR_APPOINTED: Patrick J. Heron seat on MBX Biosciences, Inc., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-08T04:45:48.730395+00:00. event_id=alpha:event:director_appointed:67y615
- DIRECTOR_APPOINTED: Steven Ryder seat on MBX Biosciences, Inc., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-08T04:45:48.730395+00:00. event_id=alpha:event:director_appointed:ai2s9e
- DIRECTOR_APPOINTED: Tiba Aynechi seat on MBX Biosciences, Inc., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-08T04:45:48.730395+00:00. event_id=alpha:event:director_appointed:13bguja
- EXECUTIVE_APPOINTED: Salomon Azoulay executive of MBX Biosciences, Inc., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-08T04:45:48.730395+00:00. event_id=alpha:event:executive_appointed:9gbno7

## Scoped resources

- `alpha://company/mbx-biosciences-inc` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record
- `alpha://company/mbx-biosciences-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=identity
- `alpha://company/mbx-biosciences-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=corporate-structure
- `alpha://company/mbx-biosciences-inc/board` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=board
- `alpha://company/mbx-biosciences-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=committees
- `alpha://company/mbx-biosciences-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=leadership
- `alpha://company/mbx-biosciences-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=ownership
- `alpha://company/mbx-biosciences-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=financials
- `alpha://company/mbx-biosciences-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=capital-structure
- `alpha://company/mbx-biosciences-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=compensation
- `alpha://company/mbx-biosciences-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=governance
- `alpha://company/mbx-biosciences-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=shareholder-governance
- `alpha://company/mbx-biosciences-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=audit
- `alpha://company/mbx-biosciences-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=legal
- `alpha://company/mbx-biosciences-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=risk
- `alpha://company/mbx-biosciences-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=cyber
- `alpha://company/mbx-biosciences-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=ai-governance
- `alpha://company/mbx-biosciences-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=agents
- `alpha://company/mbx-biosciences-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=ecosystem
- `alpha://company/mbx-biosciences-inc/events` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=events
- `alpha://company/mbx-biosciences-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=relationships
- `alpha://company/mbx-biosciences-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=assessments
- `alpha://company/mbx-biosciences-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:committee_appointment:23: `{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE OF THE BOARD OF","category":"audit","role":"member","person":{"alpha_id":"alpha:person:tiba-aynechi-mbx","name":"Tiba Aynechi"},"source_id":"governance_people_committees"}`

## Leadership

- Steven L. Hoerter: Executive Chair of the Board of Directors. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0e3ba9a231e1d171b3cab4bdbd70a9597e9bea8674aa925dec9902a169d86e74.
- Carl L. Gordon: Director. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:6. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:563ed777e89b8bccc923251990e9b4827b981c3f448c65afedf939f29ded6bfe.
- Edward T. Mathers: Director. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:7. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:563ed777e89b8bccc923251990e9b4827b981c3f448c65afedf939f29ded6bfe.
- James M. Cornelius: Director. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:8. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:563ed777e89b8bccc923251990e9b4827b981c3f448c65afedf939f29ded6bfe.
- Laurie Stelzer: Director. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0e3ba9a231e1d171b3cab4bdbd70a9597e9bea8674aa925dec9902a169d86e74.
- Ora Pescovitz: Director. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:10. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:563ed777e89b8bccc923251990e9b4827b981c3f448c65afedf939f29ded6bfe.
- Ora Pescovitz, M.D.: Director. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0e3ba9a231e1d171b3cab4bdbd70a9597e9bea8674aa925dec9902a169d86e74.
- P. Kent Hawryluk: President, Chief Executive Officer and Director. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0e3ba9a231e1d171b3cab4bdbd70a9597e9bea8674aa925dec9902a169d86e74.
- Patrick J. Heron: Director. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:13. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:563ed777e89b8bccc923251990e9b4827b981c3f448c65afedf939f29ded6bfe.
- Steven Ryder: Director. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:14. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:563ed777e89b8bccc923251990e9b4827b981c3f448c65afedf939f29ded6bfe.
- Steven Ryder, M.D.: Director. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0e3ba9a231e1d171b3cab4bdbd70a9597e9bea8674aa925dec9902a169d86e74.
- Tiba Aynechi: Director. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:16. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:563ed777e89b8bccc923251990e9b4827b981c3f448c65afedf939f29ded6bfe.
- John Smither: Interim Chief Financial Officer. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0e3ba9a231e1d171b3cab4bdbd70a9597e9bea8674aa925dec9902a169d86e74.
- P. Kent Hawryluk: President and Chief Executive Officer. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0e3ba9a231e1d171b3cab4bdbd70a9597e9bea8674aa925dec9902a169d86e74.
- Richard Bartram: Chief Financial Officer. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c44beafc8d1c67babf4337171c1655d551c9013d33731b6eb9b51642ef194feb.
- Salomon Azoulay: Chief Medical Officer. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:20. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f9b53d2a3e817284d9519e2ca489ad5217dc21d4b9c58ad831ffa9afb3039936.
- Salomon Azoulay, M.D.: Chief Medical Officer. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0e3ba9a231e1d171b3cab4bdbd70a9597e9bea8674aa925dec9902a169d86e74.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- AUDIT COMMITTEE OF THE BOARD OF: Chair not stated; Members Tiba Aynechi. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:229bc9e3a11ba2da6852a0c89ec92c17cdca28fad95534a8e7f727a43d3b3259.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- MBX Biosciences, Inc.. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b566719b54e8a764d6c74e1b437ecd10e2e6749ec864f4e7ee8ccad6384f5da5.

## Entity Status

- Public listing published. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b566719b54e8a764d6c74e1b437ecd10e2e6749ec864f4e7ee8ccad6384f5da5.

## Published Fact

- US. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b566719b54e8a764d6c74e1b437ecd10e2e6749ec864f4e7ee8ccad6384f5da5.

## Committee Appointment

- Tiba Aynechi: member, AUDIT COMMITTEE OF THE BOARD OF. Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:229bc9e3a11ba2da6852a0c89ec92c17cdca28fad95534a8e7f727a43d3b3259.

## Security Listing

- MBX (NASDAQ). Claim: alpha:claim:company:a903ee7a-3103-47c0-a978-e15cee24f109:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b566719b54e8a764d6c74e1b437ecd10e2e6749ec864f4e7ee8ccad6384f5da5.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:b566719b54e8a764d6c74e1b437ecd10e2e6749ec864f4e7ee8ccad6384f5da5: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/mbx-biosciences-inc).
- alpha:projection-evidence:document:0e3ba9a231e1d171b3cab4bdbd70a9597e9bea8674aa925dec9902a169d86e74: [SEC DEF 14A 0001193125-26-168536](https://www.sec.gov/Archives/edgar/data/1776111/000119312526168536/mbx-20260421.htm).
- alpha:projection-evidence:document:563ed777e89b8bccc923251990e9b4827b981c3f448c65afedf939f29ded6bfe: [DEF 14A mbx-20260421.htm](https://www.sec.gov/Archives/edgar/data/1776111/000119312526168536/mbx-20260421.htm).
- alpha:projection-evidence:document:c44beafc8d1c67babf4337171c1655d551c9013d33731b6eb9b51642ef194feb: MBX executive roster source.
- alpha:projection-evidence:document:f9b53d2a3e817284d9519e2ca489ad5217dc21d4b9c58ad831ffa9afb3039936: [MBX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1776111/000119312526168536/mbx-20260421.htm).
- alpha:projection-evidence:229bc9e3a11ba2da6852a0c89ec92c17cdca28fad95534a8e7f727a43d3b3259: [AUDIT COMMITTEE OF THE BOARD OF](https://www.sec.gov/Archives/edgar/data/1776111/000119312526168536/mbx-20260421.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/mbx-biosciences-inc)
- [Public Markdown](https://registry.alpha.ac/companies/mbx-biosciences-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/mbx-biosciences-inc?format=jsonld)
- MCP resource: `alpha://companies/mbx-biosciences-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-08T22:32:25.857656+00:00; recorded 2026-10-08T22:32:25.857656+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.